Spine-Tech (SPYN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Spine-Tech (SPYN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Stratajema who wrote (78)	1/28/1997 2:18:00 PM
From: Stratajema	of 242

The fast money and fearful are exiting this stock as speculation about this quarter's revenue hangs in the balance. This will be the first quarter since FDA approval and it will be a very early indicator of revenue ramp-up. I think it is unfair to judge this company after only one quarter but then again I'm not working on Wall Street. Newer analysts covering this stock have initiated hold recommendations based soley on the lofty share price, then at $22 to $28. I plan to re-establish a position in this stock after earnings are released and the downtrend abates. Regards, David

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next